Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

Po Hao Feng; Chih Teng Yu; Kuan Yuan Chen; Ching Shan Luo; Shen Ming Wu; Chien Ying Liu; Lu Wei Kuo; Yao Fei Chan; Tzu Tao Chen; Chih Cheng Chang; Chun Nin Lee; Hsiao Chi Chuang; Chiou Feng Lin; Chia Li Han; Wei Hwa Lee; Kang Yun Lee

doi:10.18632/oncotarget.25943

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

原文	英語
頁（從 - 到）	31559
頁數	1
期刊	Oncotarget
卷	9
發行號	59
DOIs	https://doi.org/10.18632/oncotarget.25943
出版狀態	已發佈 - 7月 31 2018

UN SDG

此研究成果有助於以下永續發展目標

SDG 3 良好的健康和福祉

ASJC Scopus subject areas

腫瘤科

存取文件

10.18632/oncotarget.25943

其它文件與鏈接

引用此

Feng, P. H., Yu, C. T., Chen, K. Y., Luo, C. S., Wu, S. M., Liu, C. Y., Kuo, L. W., Chan, Y. F., Chen, T. T., Chang, C. C., Lee, C. N., Chuang, H. C., Lin, C. F., Han, C. L., Lee, W. H., & Lee, K. Y. (2018). Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146. Oncotarget, 9(59), 31559. https://doi.org/10.18632/oncotarget.25943

Feng, PH, Yu, CT, Chen, KY , Luo, CS , Wu, SM, Liu, CY, Kuo, LW, Chan, YF, Chen, TT , Chang, CC , Lee, CN , Chuang, HC , Lin, CF , Han, CL , Lee, WH & Lee, KY 2018, 'Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146', Oncotarget, 卷 9, 編號 59, 頁 31559. https://doi.org/10.18632/oncotarget.25943

@article{39e4bed62fa24ba59979ab3627b63035,

title = "Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146",

abstract = "This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.",

author = "Feng, \{Po Hao\} and Yu, \{Chih Teng\} and Chen, \{Kuan Yuan\} and Luo, \{Ching Shan\} and Wu, \{Shen Ming\} and Liu, \{Chien Ying\} and Kuo, \{Lu Wei\} and Chan, \{Yao Fei\} and Chen, \{Tzu Tao\} and Chang, \{Chih Cheng\} and Lee, \{Chun Nin\} and Chuang, \{Hsiao Chi\} and Lin, \{Chiou Feng\} and Han, \{Chia Li\} and Lee, \{Wei Hwa\} and Lee, \{Kang Yun\}",

note = "Publisher Copyright: {\textcopyright} Feng et al.",

year = "2018",

month = jul,

day = "31",

doi = "10.18632/oncotarget.25943",

language = "English",

volume = "9",

pages = "31559",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "59",

}

TY - JOUR

T1 - Correction

T2 - S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

AU - Feng, Po Hao

AU - Yu, Chih Teng

AU - Chen, Kuan Yuan

AU - Luo, Ching Shan

AU - Wu, Shen Ming

AU - Liu, Chien Ying

AU - Kuo, Lu Wei

AU - Chan, Yao Fei

AU - Chen, Tzu Tao

AU - Chang, Chih Cheng

AU - Lee, Chun Nin

AU - Chuang, Hsiao Chi

AU - Lin, Chiou Feng

AU - Han, Chia Li

AU - Lee, Wei Hwa

AU - Lee, Kang Yun

PY - 2018/7/31

Y1 - 2018/7/31

N2 - This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

AB - This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

UR - https://www.scopus.com/pages/publications/85050959141

UR - https://www.scopus.com/pages/publications/85050959141#tab=citedBy

U2 - 10.18632/oncotarget.25943

DO - 10.18632/oncotarget.25943

M3 - Comment/debate

C2 - 30140390

AN - SCOPUS:85050959141

SN - 1949-2553

VL - 9

SP - 31559

JO - Oncotarget

JF - Oncotarget

IS - 59

ER -

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

摘要

UN SDG

ASJC Scopus subject areas

存取文件

其它文件與鏈接

指紋

引用此